1 / 6

U.S. Compression Therapy Market

Rise in prevalence of diabetes, lymphatic diseases, increase in older age population, and rise in number of orthopedic procedures due to increase in number of sports injuries & accidents are the factors that are expected to drive the growth of the U.S. compression therapy market

newmarketindustry
Télécharger la présentation

U.S. Compression Therapy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Compression Therapy Market

  2. Compression therapy is a simple & effective process of applying external pressure to the lower limbs. It is used to treat different chronic diseases. It involves wearing specially designed hosiery, bandages, and tapes for evaluating blood circulation in legs. Compression therapy is an effective technique used for conditions such as Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT), chronic & diabetic ulcers, post-thrombotic syndrome, and lymphedema. It reduces pathologically increased venous pressure. Get Sample Report

  3. In addition, it improves moment of joints and tendons, and reduces inflammation. This treatment is prescribed to treat phlebitis, post vein surgery, thrombosis, varicose veins, venous leg ulcers, and vein thrombosis. Moreover, it is prescribed to prevent venous trouble during long distance travel and pregnancy. During the therapy, vibration of muscles is reduced and delayed soreness of muscle is prevented. Available products for compression therapy include carolon stockings, farrow wraps, jobstulcercare compression stockings, and circaid juxta-lite.

  4. Rise in prevalence of diabetes, lymphatic diseases, increase in older age population, and rise in number of orthopedic procedures due to increase in number of sports injuries & accidents are the factors that are expected to drive the growth of the U.S. compression therapy market during the forecast period. In addition, rise in number of cases of deep vein thrombosis, leg ulcers, and varicose veins are expected to drive the market growth in the coming years. Moreover, technological advancements in the healthcare sector, rise in awareness regarding the compression therapy, and advancements in the bandages & compression stockings manufacturing industry are expected to boost the growth of the U.S. compression therapy market during the forecast period.

  5. KEY BENEFITS FOR STAKEHOLDERS • This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which assists to identify the The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026, in terms of value. • An extensive analysis of various regions provides insights that is expected to allow companies to strategically plan their business moves. • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the U.S. compression therapy market.

  6. Some of the major players operating in the U.S. compression therapy market include Medtronic PLC, 3M Company, BSN Medical, Bio Compression Systems, Inc., Paul Hartmann AG, Medi GmbH & Co. Kg, Cardinal Health, Inc., Smith & Nephew PLC., Sanyleg S.R.L., Sigvaris, Tactile Medical, Convatec Inc., Julius Zorn GmbH, Arjohuntleigh (Subsidiary of Getinge Group), and DJO Global Inc.

More Related